COVID-19 – Launch of production phase of EasyCov, a saliva-based screening test, with market entry in France and Europe set for June.


The consortium formed by the biotechnology company SKILLCELL, a subsidiary of the ALCEN group, the CNRS SYS2DIAG laboratory (CNRS/ALCEN) and the digital company VOGO announces the production and marketing phases of the saliva test for the detection of SARS-COV-2 called EasyCov. There is already an efficient and reliable development, manufacture and distribution chain in place to prepare the swift deployment of the test.


Press office
Jennifer Julia
VOGO press office
CNRS Press Office